Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Senseonics HoldingsSENS +0.39%56 Receivables Turnover is 0.87 as of Mar. 2026. GuruFocus rates SENS with a GF Score™ of 56/100 and a GF Value™ of $14.47 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 811 Medical Devices & Instruments companies, Senseonics Holdings ranks worse than 65.47% on this metric.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Senseonics Holdings's Revenue for the
three
months ended in Mar. 2026 was $11.71 Mil. Senseonics Holdings's average Accounts Receivable for the
three
months ended in Mar. 2026 was $13.42 Mil.
Hence, Senseonics Holdings's Receivables Turnover for the
three
months ended in Mar. 2026 was 0.87.
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Senseonics Holdings Receivables Turnover Related Terms
Senseonics Holdings Receivables Turnover Historical Data
* Premium members only.
The historical data trend for Senseonics Holdings's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SENS vs LAB, TMCI, SGHT: Receivables Turnover Comparison
For the Medical Devices subindustry, Senseonics Holdings's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Senseonics Holdings Receivables Turnover vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Senseonics Holdings's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Senseonics Holdings's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Senseonics Holdings (SENS) has a Receivables Turnover of 0.87 as of Mar. 2026. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Senseonics Holdings and its competitors. According to the industry distribution chart, Senseonics Holdings ranks #531 out of 811 companies in the Medical Devices & Instruments industry, placing it in the top 65.5%.
Is Senseonics Holdings' Receivables Turnover too high?
Senseonics Holdings' current Receivables Turnover is 0.87. The Medical Devices & Instruments industry median Receivables Turnover is 5.51. Senseonics Holdings' value of 0.87 is 84.2% below this industry median. Based on the distribution chart, Senseonics Holdings ranks #531 out of 811 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Senseonics Holdings has a GF Score™ of 56/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Senseonics Holdings' Receivables Turnover compare to LAB and TMCI?
According to the Medical Devices & Instruments industry distribution chart, Senseonics Holdings ranks #531 out of 811 companies for Receivables Turnover. This places Senseonics Holdings in the lower half of its industry. The industry median Receivables Turnover is 5.51. Senseonics Holdings' value of 0.87 is 84.2% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Medical Devices & Instruments company?
The median Receivables Turnover among Medical Devices & Instruments companies is 5.51, based on 811 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Senseonics Holdings's current Receivables Turnover of 0.87 is 84.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Senseonics Holdings and its competitors. For the Medical Devices & Instruments industry, the median Receivables Turnover is 5.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Senseonics Holdings's current Receivables Turnover is 0.87. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Senseonics Holdings stock overvalued right now?
Based on GuruFocus' analysis, Senseonics Holdings (SENS) is currently considered Possible Value Trap. The stock's GF Value™ is $14.47, compared to a current price of $5.13 — trading 64.6% below its estimated fair value. The current Receivables Turnover is 0.87 and 84.2% below the Medical Devices & Instruments industry median of 5.51. Senseonics Holdings' overall GF Score™ is 56/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Senseonics Holdings (SENS), the current Receivables Turnover is 0.87 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Senseonics Holdings (SENS) Overvalued in 2026?
Based on GuruFocus' analysis, Senseonics Holdings stock appears to be undervalued.
The current stock price of $5.13 is trading 64.6% below its estimated GF Value™ of $14.47.
GuruFocus considers Senseonics Holdings to be Possible Value Trap.
Key valuation signals for SENS:
Receivables Turnover: 0.87
GF Value™: $14.47 vs. price of $5.13 (64.6% below fair value)
Industry Position: 84.2% below the Medical Devices & Instruments median (#531 of 811)
No single metric tells the full story. See the SENS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Senseonics Holdings Inc is a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system to improve the lives of people with diabetes by enhancing their ability to manage their disease with relative ease and accuracy. Its implantable CGM system, Eversense, including Eversense E3 and Eversense 365 CGM systems, measures glucose levels via an under-the-skin sensor, a removable and rechargeable smart transmitter, and an app for real-time diabetes monitoring and management. The company operates through one reportable segment which derives its revenues from diabetes products and services and generates the majority of its revenue from the United States.
56GF Score
Get the complete analysis for SENS
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SENS has been successfully added to your 
